| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fresh Tracks Therapeutics, Inc. | President and CEO | Common Stock | 39,269 | $38,876 | $0.9900 | 02 Oct 2023 | Direct |
| Fresh Tracks Therapeutics, Inc. | President and CEO | Restricted Stock Units | 0 | $0.9100 | 02 Oct 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000162828023033916-sklawer-andrew-d-2023-10-02 | Fresh Tracks Therapeutics, Inc. | 02 Oct 2023 | 3 | -$20,412 | 4 | President and CEO | 04 Oct 2023, 21:41 |
| /report/000081905023000007-sklawer-andrew-d-2023-01-24 | Fresh Tracks Therapeutics, Inc. | 24 Jan 2023 | 1 | $0 | 4 | President | 26 Jan 2023, 17:49 |
| /report/000081905022000039-sklawer-andrew-d-2022-05-05 | Brickell Biotech, Inc. | 05 May 2022 | 1 | $0 | 4 | COO and Secretary | 09 May 2022, 16:07 |
| /report/000081905021000089-sklawer-andrew-d-2021-06-14 | Brickell Biotech, Inc. | 14 Jun 2021 | 1 | $0 | 4 | COO and Secretary | 14 Jun 2021, 16:45 |
| /report/000106299321004868-sklawer-andrew-d-2021-05-17 | Brickell Biotech, Inc. | 17 May 2021 | 1 | +$12,300 | 4 | COO and Secretary | 19 May 2021, 17:03 |